99 related articles for article (PubMed ID: 10355082)
1. [Immunocytochemical and molecular proof of disseminated tumor cells in bone marrow, peritoneal lavage, blood and regional lymph nodes. A review of the literature and own results].
Broll R; Windhövel U; Schiedeck T; Duchrow M; Bruch HP
Zentralbl Chir; 1999; 124(4):286-91. PubMed ID: 10355082
[TBL] [Abstract][Full Text] [Related]
2. [Minimal residual disease in gastrointestinal tumors: tumor detection in bone marrow, blood and lymph nodes].
Rosenberg R; Nekarda H; Thorban S; Siewert JR
Acta Med Austriaca Suppl; 2002; 59():42-53. PubMed ID: 12506760
[TBL] [Abstract][Full Text] [Related]
3. Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.
Vlems FA; Wobbes T; Punt CJ; Van Muijen GN
Anticancer Res; 2003; 23(1B):523-30. PubMed ID: 12680140
[TBL] [Abstract][Full Text] [Related]
4. Detection of disseminated colorectal cancer cells in lymph nodes, blood and bone marrow.
Weitz J; Kienle P; Magener A; Koch M; Schrödel A; Willeke F; Autschbach F; Lacroix J; Lehnert T; Herfarth C; von Knebel Doeberitz M
Clin Cancer Res; 1999 Jul; 5(7):1830-6. PubMed ID: 10430088
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and significance of minimal residual disease in patients with colorectal carcinoma].
von Knebel Doeberitz M; Koch M; Weitz J; Herfarth C
Zentralbl Chir; 2000; 125 Suppl 1():15-9. PubMed ID: 10929641
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of isolated tumor cells and micrometastases in patients with gastric carcinoma].
Kodera Y; Nakanishi H; Ito S; Nakao A
Gan To Kagaku Ryoho; 2007 Jun; 34(6):817-23. PubMed ID: 17565240
[TBL] [Abstract][Full Text] [Related]
7. Impact of disseminated tumor cells in gastrointestinal cancer.
Thorban S; Rosenberg R; Maak M; Friederichs J; Gertler R; Siewert JR
Expert Rev Mol Diagn; 2006 May; 6(3):333-43. PubMed ID: 16706737
[TBL] [Abstract][Full Text] [Related]
8. Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma.
Vogel I; Kalthoff H; Henne-Bruns D; Kremer B
Pancreatology; 2002; 2(2):79-88. PubMed ID: 12123098
[TBL] [Abstract][Full Text] [Related]
9. Detection and clinical significance of occult tumour cells in colorectal cancer.
Tsavellas G; Patel H; Allen-Mersh TG
Br J Surg; 2001 Oct; 88(10):1307-20. PubMed ID: 11578283
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotype of isolated tumour cells in the blood, bone marrow and lymph nodes of patients with gastric cancer.
Pituch-Noworolska A; Drabik G; Szatanek R; Białas M; Kołodziejczyk P; Szczepanik A; Stachura J; Zembala M
Pol J Pathol; 2007; 58(2):93-7. PubMed ID: 17715675
[TBL] [Abstract][Full Text] [Related]
11. International Union Against Cancer. Classification of isolated tumor cells and micrometastasis.
Hermanek P; Hutter RV; Sobin LH; Wittekind C
Cancer; 1999 Dec; 86(12):2668-73. PubMed ID: 10594862
[TBL] [Abstract][Full Text] [Related]
12. Detection of disseminated tumor cells: strategies and diagnostic implications.
Zehentner BK
Expert Rev Mol Diagn; 2002 Jan; 2(1):41-8. PubMed ID: 11963801
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
14. The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.
Pfitzenmaier J; Ellis WJ; Hawley S; Arfman EW; Klein JR; Lange PH; Vessella RL
Urol Oncol; 2007; 25(3):214-20. PubMed ID: 17483018
[TBL] [Abstract][Full Text] [Related]
15. Disseminated tumor cells versus micrometastasis: definitions and problems.
Hermanek P
Anticancer Res; 1999; 19(4A):2771-4. PubMed ID: 10470239
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
17. [The detection of tumor cells in the bone marrow, peripheral blood and leukapheresis products in breast carcinoma patients].
Zhong XY
Dtsch Med Wochenschr; 2000 Jul; 125(27):840-4. PubMed ID: 10929540
[No Abstract] [Full Text] [Related]
18. [Simultaneous immunocytochemical detection of tumor cells in lymph nodes and in bone marrow of patients with resectable bronchial carcinomas].
Passlick B; Pantel K; Kubuschok B; Izbicki JR; Thetter O
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):21-4. PubMed ID: 14518204
[TBL] [Abstract][Full Text] [Related]
19. Micrometastases in axillary lymph nodes and bone marrow of lymph node-negative breast cancer patients--prognostic relevance after 10 years.
Gebauer G; Fehm T; Merkle E; Jaeger W; Mitze M
Anticancer Res; 2003; 23(5b):4319-24. PubMed ID: 14666645
[TBL] [Abstract][Full Text] [Related]
20. Biological implications of tumor cells in blood and bone marrow of pancreatic cancer patients.
Z'graggen K; Centeno BA; Fernandez-del Castillo C; Jimenez RE; Werner J; Warshaw AL
Surgery; 2001 May; 129(5):537-46. PubMed ID: 11331445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
